Notification of sale of treasury shares as of 14 August, 2025
Sofia, Bulgaria, August 14,
Sofia, Bulgaria, August 14,
Sofia, Bulgaria, August 13,
Sofia, Bulgaria, August 12,
Sofia, Bulgaria, August 6, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 5, 2025 the Company sold 3 831 544 (three million eight hundred thirty-one thousand five hundred forty-four) repurchased own shares representing 0.71% of the share capital of the Company, at a total value of BGN 9 311 051.92 on the Bulgarian Stock Exchange, the average price per share was BGN 2.43.
Sofia, Bulgaria, August 6, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 4, 2025 the Company sold 770 286 (seven hundred thousand two hundred eighty-six) repurchased own shares representing 0.14% of the share capital of the Company, at a total value of BGN 1 871 797.84 on the Bulgarian Stock Exchange, the average price per share was BGN 2.43.
Sofia, Bulgaria, August 5, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) corrects the text of the following notifications regarding sold repurchased shares due to a technical mistake as follows:
In notification of sale of treasury shares as of July 31, 2025:
The text:
“The total number of treasury shares after this transaction is 26 060 100 representing 4.83% of the share capital of the Company.”
Sofia, Bulgaria, August 4, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 1, 2025 the Company sold 10 500 (ten thousand five hundred) repurchased own shares representing 0.002% of the share capital of the Company, at a total value of BGN 25 625.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.44.
Sofia, Bulgaria, August 1, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on July 31, 2025 the Company sold 2 400 (two thousand four hundred) repurchased own shares representing 0.0004% of the share capital of the Company, at a total value of BGN 5 778.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.41.
Sofia, Bulgaria, July 31, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on July 30, 2025 the Company sold 28 500 (twenty-eight thousand five hundred) repurchased own shares representing 0.01% of the share capital of the Company, at a total value of BGN 68 969.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.42.